Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesIdentification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
Neuro-Oncology, 10/06/09
Brekke HR et al. – This is the most comprehensive study of in situ protein expression in MPNST so far, and expressed p53 was found to be a strong surrogate marker for outcome. Patients in complete remission with a primary p53–positive MPNST diagnosis may be considered in a high–risk subgroup and candidates for adjuvant treatment.
Related Articles
Malignant Peripheral Nerve Sheath Tumor of the Renal Pelvis
Urologia Internationalis, 10/22/09
Relevance Score: 81%
Surgical strategies for managing foraminal nerve sheath tumors: the emerging role of CyberKnife ablation
European Spine Journal, 10/13/09
Relevance Score: 81%
Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis
Oncogene, 11/12/09
Relevance Score: 80%
Plexiform Fibromyxoma: A Distinctive Benign Gastric Antral Neoplasm Not to be Confused With a Myxoid GIST
American Journal of Surgical Pathology, 10/28/09
Relevance Score: 79%
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours
The Journal of Pathology, 11/09/09
Relevance Score: 68%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
Journal of Neuro-Oncology, 12/17/09
Secretory meningiomas: A benign subgroup causing life-threatening complications
Neuro-Oncology, 12/17/09
Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array
Neuro-Oncology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor